Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.
Takahashi
K
K
Tokyo Women's Medical College, Japan.
Ochiai
T
T
Uchida
K
K
Yasumura
T
T
Ishibashi
M
M
Suzuki
S
S
Otsubo
O
O
Isono
K
K
Takagi
H
H
Oka
T
T
D000017:ABO Blood-Group System; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003141:Communicable Diseases / Q000453:epidemiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007564:Japan; D007674:Kidney Diseases / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010865:Pilot Projects; D016019:Survival Analysis
D000017:ABO Blood-Group System; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid